NCT06957782View on ClinicalTrials.gov

The Value of 68Ga-FAPI PET/CT for Evaluating Peritoneal Treatment Response

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2027

Conditions

Peritoneal MetastasisFAPI

Interventions

DRUG

⁶⁸Ga-FAPI-46

All patients will be administered with 1.5 MBq/kg ⁶⁸Ga-FAPI-46. ⁶⁸Ga-FAPI-46 will be injected intravenously followed by a flush injection of 10 mL of saline following routine procedures.